Best MRI of one area gastroenterologists: TOP 473 doctors

 CURRICULUM VITAE. José E. Batista-Miranda PhD MD  Jan 2025 

Correspondence (Uroclinica Center) : Via Augusta 158. Barcelona, Spain               

Hospital: Centro Medico Teknon/ Grupo Quironsalud,  Vilana 12. 08021  Barcelona, Spain. 

Phone: 34- 687  99 54 57

Qualification: Qualfied urologist in Spain and UK (GMC specialist list) 

Current position.  Urodynamics Head and Consultant Urologist, CM Teknon, Barcelona, since 1996

                                    Director, Uroclinica Team and Continentia Association ( continentia.org)

                                    Co- director: Functional Urology program UAX University, Madridr     

Previous professional Experience

2005- Senior Clinical Chief in Urodynamics. Hospital Vall d´Hebron. Barcelona. 

1995-2003 Consultant Urologist. Urodynamics and Oncology Units. F. Puigvert, Barcelona.

1994 Fellow in Neuro-Urology. Boston University (Drs. Krane & Siroky) and Harvard´s Children´s Hospital (Dr. Bauer) Boston, USA (La Caixa grant).

1994- Registrar. Bristol Urological Institute,U.K.(Mr. Abrams) (Research Council grant)

Current Professional Practice: experience

Head of Urodynamics: on line reporting of over 2000 studies / year at 5 different locations. 

General urology and functional urology clinic. 

Surgery:

1. Thulim and green-light laser vaporization (first case in Barcelona in 2003) .
2. Holmium enucleation (HOLEP)
3. HIFU focal treatment and MRI fusion biopsies
4. Ambulatory flexible cystoscopy
5. Fistula and incontinece surgery: vesico-vaginal fistula, TVT, bladder augmentation
6. Female urethral surgery: diverticula, para- urethral cysts.
7. Ureteroscopy and laser surgery for stones
8. General pediatric urologic surgery: scrotal and  preputial surgery

Urological and post-graduate training.

1997- PhD Thesis, Aut. Univ. of Barcelona (“Oxybutinin in children”) (Spanish Urol. Ass. Prize)

1994- Certified Urologist (Ministries of Health & Education)

1991-Urology Dept,USC Hospital, Los Angeles, CA.(Dr.Skinner) (Research Council grant)

1989-93- Residency in Urology. Fundacio Puigvert-National MIR program. (Dr. Solé Balcells).

Medical Education 

1981-87-Medical Degree, Universidad Autonoma de Barcelona (UAB). 1st Class Degree.

1985 & 86- Intern. Department of Surgery. Keiserin Elisabeth Spital, Viena, Austria.

1988-ECFMG Certificate (Permannent validation:February 1994)

Publications  

103 papers in journals: including 25 in international Journals (see annex)

Editor of 2 books on clinical cases in Urodynamics. 

Chapters in 4 books.

Co-editor "Impact Spanish Urology"

Translations for Br J Surgery, Advances in Urology, WHO/ICUD consultations . 

Presentations at congresses

45, including 28 at international congresses (Eur. Ass. Urol, Am Urol Ass, ICS, SIU, see annex).

Post-graduate teaching ( President, “Continentia association” www.continentia.org ) 

23 ICS accredited courses on Urodynamics  ( 5 English editions for Crotatia, Slonvenia, Hugary, Romania and Bulgaria) 

9 CME international/ multi specialty study days on functional urology and urogynechology 

Courses and talks at ICS and European Ass. meetings. 

Pre-graduate teaching

2010- Bladder dysfunction module. Faculty of Medicine, Aut. Univ of Barcelona

1990-92 Director: Basic Medical English Course for students. Autonomous Univ. of Barcelona.

1992-93 Clinical tutor in Urology (including seminars) Autonomous Univ. of Barcelona .

Invited / elected committee membership and  post graduate lecturer

WHO´s International Consultation on BPH (1995, 97, 2000)

WHO´s  International Consultation on Incontinence (1999, 2001)

Member, Ethics Committee, BarcelonaMedical College.

Secretary, Institutional Review Board (Ethics Research committee. F. Puigvert)

Clinical tutor ellected by Urology residents.

Invited speaker  in courses / symposiums in Spain, Mexico, Morocco and Italy.

Research projects / IRB approved trials / advisor. 

1993- IPSS validation in Spanish

1994- Epristeride phase III clinical trial (Boston University)

1994- Bladder blood flow evaluation (Boston University)

1995- Cavidox (Quality of life in BPH patients, Almirall Laboratories)

1996- Tamsulosin phase IV clinical trial (Boehringer Laboratories)

1996- Vesica international surgical study (Boston scientific) 

1997- European endourology panel (Boston scientific)

1997- YM 905, phase II clinical trial (Yamanouchi/ Astellas)

1998- present: Detrusor morphometry in obstruction (PhD thesis co-director)

2000- European panel on appropriate management on BPH (Erasmus University)

2001- Quality of life in radical prostatectomy vs brachytherapy. Use of FACT questionnaire.

2004- Effect of Aclidinium in  Urology  ( Almirall laboratories) 

2008- 2015: Nocturia Study ( Astellas Europe)

2012- “Beyond” ( Astellas Multicenter study on Mirabegron) Principal Investigator

2014- Belive ( Astellas post- commercialization study) 

2015- VHEA ( Hiperactive bladder in aging population, multicenter group; Principal investigator)

2019- Flow taker monitorization for nocturia ( Astellas grant)

2022- Idorsia Phase 3 nocturia study

2024- 3 researcher led studies: Ambulatory urodynamics register, Virtual reality, Tensi for overactive blader. 

WHO´s International Consultation on BPH (1995, 97, 2000)

WHO´s International Consultation on incontinence (1999, 2001)

MEMBERSHIP. Spanish Urol.Ass, ICS.

Since 1998 he has been Director of the Epilepsy Unit at the Ruber International Hospital in Madrid, a pioneering centre for the diagnosis, medical and surgical treatment of epilepsy in children and adults.

More than 150 neurologists and neurophysiologists from Spain and Latin America have been trained here, and several of its students have successfully opened epilepsy centres in other public and private hospitals, both in Spain and abroad.

The program he directs has become a pioneer in Spain in the field of genetic diagnosis of complex epilepsies and advanced treatments such as drug repositioning, interstitial laser treatment, deep electrodes and gamma radiosurgery, which are used in patients with refractory epilepsy.

Dr. Antonio Gil-Nagel is a professor at the IE University, is an Ad Honorem Professor at the Center for Biomedical Technology of the Polytechnic University of Madrid (CTB) and is Director of the Epilepsy Department at the Francisco Vitoria University of Madrid.

He was a founding member of the European Epilepsy Research Network and the European Association for Epilepsy Monitoring. He is also active in international research projects such as EpiCare and the European Epilepsy Brain Bank and has held relevant positions in international institutions such as the International Bureau for Epilepsy (IBE), the International League Against Epilepsy (ILAE), the European Federation of Neurological Societies (EFNS) and the World Federation of Neurology (WFN).

Dr. Gil-Nagel has directed numerous clinical trials and research studies in the field of epilepsy, especially in orphan epilepsies such as Dravet syndrome, Lennox-Gastaut syndrome and other epileptic and developmental encephalopathies. The Epilepsy Program he directs is an international benchmark in the development of pharmacological research. He has been the Principal Investigator of phase II and III clinical trials, including numerous clinical trials and non-pharmacological treatments (epilepsy surgery, electrical stimulation, ketogenic diet and gamma knife). His research is funded by European Union funds and the Public Innovation Agency of the Ministry of Science and Innovation of the Spanish Government. Their dedication to research and the development of new treatments allows them to accelerate the treatment of their patients with new treatments.

In addition to being a frequent speaker at national and international conferences, he has authored several books on epilepsy and electroencephalography and has numerous publications on epilepsy in journals such as Annals of Neurology, Brain, Epilepsy, European Journal of Neurology, Journal of Neurology, Nature Neurology, Neurology, and the New England Journal of Medicine, among others. He has authored 165 Scopus-indexed articles with 5,265 citations and an h-index of 35.

In 2021, his team received the Innovative Small and Medium Enterprise Award for the project on mesial temporal lobe epilepsy and encephalocele (Ministry of Science and Innovation, Spain), and in 2012, the Scientific Award from the Epilepsy Group of the Spanish Society of Neurology (SEN).

Education

• 1985 – Bachelor of Medicine and Surgery , Complutense University of Madrid.
• 1986-1989 – Specialization in Neurology , Hospital 12 de Octubre, Madrid.
• 1991–1993 – Epilepsy Specialist , Comprehensive Epilepsy Program, University of Minnesota, Minneapolis, USA.
• 1997 – Certification of the American Board of Clinical Neurophysiology .

Professional experience

• 1993–1995 – Associate Professor, Epilepsy Program, Department of Neurology, University of Minnesota, Minneapolis, USA.
• 1995–1998 – Associate Professor, Epilepsy Program, Department of Neurological Sciences, Rush-Presbyterian-St. Luke's Medical Center, Chicago, USA.
• Since 1998 – Director of the Epilepsy Program , Neurology Service, Ruber International Hospital, Madrid.
• 2014 – Defense of the dissertation on the topic: "Clinical and neurophysiological studies in the pre-surgical evaluation of epilepsy" , Complutense University of Madrid.
• 2022 – Deputy Head of the Neurology Service , Ruber Internacional International Hospital, Madrid.

Membership in professional societies

• Since 1991 – Member of the American Academy of Neurology (AAN).
• Since 1991 – Member of the American Epilepsy Society (AES).
• Since 1996 – Member of the American Society of Clinical Neurophysiology .
• Since 1988 – Member of the Spanish Society of Neurology .
• Since 2006 – Representative of Spain in the World Federation of Neurology (WFN).
• Since 2006 – Member of the editorial committee and the WFN web portal .
• Since 2008 – Director of the Epilepsy Group of the European Federation of Neurological Societies (EFNS).
• Since 2009 – Member of the EFNS Educational Courses Committee.
• 2007–2009 – Member of the EFNS Scientific Committee .
• 2007–2008 – Vice-President of the Scientific Committee of the 12th EFNS Congress , Madrid.
• 2004–2007 – Delegate of Spain to the EFNS .
• 2009 – Member of the Scientific Committee of the World Congress of Neurologists , Marrakech.

Outstanding Achievements

Dr. Hill-Nagel is a leading international figure in the field of epileptology, a recognized expert in the diagnosis and treatment of genetic epilepsy and the surgical approach to its correction. His distinguished professional career includes many years of experience in leading medical institutions in the United States and Europe, as well as active participation in international research and educational programs.

Dr. Hill-Nagel not only advances the science of neurology on a global level, but also successfully implements cutting-edge treatment methods, improving the lives of thousands of patients around the world.

Key facts and achievements

• - More than 20 years of experience in the treatment of complex pathologies of the brain using Gamma Knife radiosurgery , including functional disorders and tumor diseases.
• -Works in a team with Dr. Roberto Martinez Alvarez , a world-leading neurosurgeon and Gamma Knife specialist, providing a unique multidisciplinary approach to patient care.
• - International experience : Studied and collaborated with leading global institutions, including the Gregorio Marañon in Madrid and the Gustave Roussy Institute in Paris.

Specialization

• More than 7,000 patients have been treated in the Radiosurgery Department, including:
• - Benign tumors : meningiomas, schwannomas, pituitary adenomas.
• - Malignant pathologies : brain metastases and CNS tumors.
• - Vascular pathologies : arteriovenous malformations, cavernomas and fistulas.
• - Functional disorders : refractory epilepsy, tremor, trigeminal neuralgia and obsessive-compulsive disorder.

Scientific and professional activities

• - Member of the international Gamma Knife Consortium , led by the University of Pittsburgh .
• - Author of scientific research and protocols for the treatment of cancer using radiotherapy.
• - Participated in the development of the innovative project "Fusion of Medical Images" as part of oncology research.

Experience

2002-present | Attached to the Department of Gamma Radiosurgery and Functional Neurosurgery of Ruber International Hospital.

2002-2007 | Assistant, Department of Radiation Oncology, Ruber International Hospital.

2002| Medical Affairs Manager Medical Department Janssen-Cilag, SA Madrid

Qualification

2012|Doctor of Medicine and Surgery Madrid. Department of Surgery, Autonomous University of Madrid. Spain

2001 | Specialist in Radiation Oncology at the Gregorio Marañón University Hospital in Madrid. Training completed at the Gustave-Roussy Institute in Paris in 2000.

1995 | Graduate of the Faculty of Medicine and Surgery, Complutense University of Madrid. Spain.

2016-present | Member of the Ruber International Hospital Gamma Knife Radiosurgery Team, International Gamma Knife Consortium: Led by the Pittsburgh Hospital.

1999-2000| Project Manager: "Protocol for Pamidronate Treatment of Breast Cancer Patients with Predominantly Lytic Bone Metastases"

1999 | GICOR Study: "Incidence of Anemia in Patients Receiving Radiation Therapy"

1999 | GICOR study: "Androgen deprivation protocol associated with radiation therapy for localized high-risk prostate cancer"

1997-2001|Participant (collaborator) in the research project (FIS FELLOWSHIP): "Multimodal fusion of medical images in oncology" at HGU Gregorio Marañon. Project leader: Dr. Desco Menéndez.

Teaching :

2018-present|Professor of the International Master of Radiosurgery of the Central Nervous System at the Complutense University of Madrid.

2020-present|Professor at the School of Radiosurgery of the Spanish Society of Neurosurgeons.

2017-2019|Professor of the Master of Radiosurgery and Clinical Stereotactic Radiotherapy of the Spanish Society of Radiation Oncology.

2017 - 2022| Member of the Dissertation Committee in Radiosurgery three times at the Autonomous University of Madrid and the Complutense University of Madrid.

2011-2012|Professor, International Master's Program in Advanced Technological Applications in Radiation Oncology, 3rd ed.

2001-2002|Associate Professor of Dentistry at the Alfonso X El Sabio University.

1998 - 2001|Professor of the secondary school I.E. Technical and vocational school of health K.A.M. (Radiation oncology technicians and archival technicians).

Publications

2022|Stereotactic radiosurgery of obsessive-compulsive disorders. Chapter. 25. Book: Intracranial stereotactic radiosurgery. ed. 2022. Pages: 251-256.

2022|Active monitoring and stereotactic radiosurgery provide a low risk of symptoms associated with incident frontobasal meningioma, but stereotactic radiosurgery provides better radiological control – a subanalysis of the IMPASSE trial. Cancers 2022; 14(5).1300. https://doi.org/10.3390/cancers14164047

2022|Stereotactic radiosurgery for Kuss grade IV vestibular schwannoma: a multi-institutional study. Journal of Neurosurgery. 2022 Jun 3; DOI: 10.3171/2022.4.JNS22203.

2022|Stereotactic radiosurgery for Rathke's cleft cyst: an international multicenter study. J Neurosurg 137: 1041–1046, 2022. DOI: 10.3171/2021.12.JNS212108.

2021|Surgery and radiosurgery in autism: a retrospective study on 10 patients. Stereotactic Function Neurosurgery. 2021;99(6):474–483. 15.

Presentations

2019| "Other indications in malignant tumor pathology" Cranial Radiosurgery Conference. Valencia 2019.

2018| Gamma Knife Radiosurgery: Concept, Equipment and Treatment Description I Scientific Conference on Gamma Knife Radiosurgery, Madrid, 2018

2018|Radiotherapy and protons in children. XX meeting of the SENEC Working Group on Neuro-Oncology:. Madrid.

2015| "Visualization monitoring of response and complications of brain treatment". XVIII National Congress of S.E.O.R. Valencia

2015 | Gamma Knife Radiosurgery in the Treatment of Refractory Epilepsy Associated with Nodular Heterotopia: Long-Term Safety and Efficacy. Congress of the Spanish Society of Neurology.

Communities it belongs to:

-SER, Spanish Society of Radiosurgery (she currently serves on the Board of Directors as Treasurer)

-SEOR, Spanish Society of Oncological Radiotherapy: Working Groups "Brain Tumors (NEUROONCOR)" and "Radiation Oncology Activities in the Private Sector"

-SSRI, International Society for Stereotactic Radiosurgery

- Member of the Oncology Group of the Spanish Society of Neurosurgery (SENEC).

Dr. Nuria Martínez Moreno , working in tandem with Dr. Roberto Martínez Álvarez, combines expert oncology knowledge and high-precision radiosurgery technology , providing patients with the most advanced and effective treatment in Spain.

Professional experience

• 2018 – present : Head of the Traumatology Department at the International Orthopaedic Center Hospital Ruber Internacional in Madrid.
• 2000 – 2018 : Specialist in Hip and Knee Surgery at the International Center Hospital Ruber Internacional, Madrid.
• Until 2000 : Deputy Head of the Traumatology Department at the Hospital J. Puerta de Hierro, Madrid.

Education and qualifications

• 1992 : Medical degree from the Faculty of Medicine and Surgery of the Autonomous University of Madrid.
• Specialization in Orthopedic Surgery and Traumatology at the Puerta de Hierro Hospital.

Scientific research and clinical trials

1. Phase 2B : Efficacy and safety study of PD 0348292 for the prevention of venous thromboembolic events (VTE) in patients undergoing total knee arthroplasty.
2. CV185-047 : Comparison of the efficacy of apixaban and enoxaparin for the prevention of VTE.
3. CV185-035 : A study of prevention of deep vein thrombosis after hip replacement.
4. PRADAXA® 1160.85 : A study of the efficacy of dabigatran etexilate for the prevention of VTE following hip and knee surgery.
5. PRADAXA® 1160.84 : Evaluation of the safety of dabigatran in patients with moderate renal impairment after total renal arthroplasty.

Learning and Teaching

• 1997–2000 : Associate Professor, Department of Traumatology, Puerta de Hierro Hospital, Madrid.

Specialization and innovation

• Knee replacement : Using the latest generation navigation systems, Rapid Recovery and ERAS protocols for accelerated recovery.
• Hip Replacement : Minimally Invasive Techniques and Improved Restorative Protocols.
• Arthroscopic surgery : Treatment of diseases of the knee and hip joints.
• Non-surgical treatment : Introduction of innovative infiltration techniques for joint pathology.

Recognition and achievements

• 2022 : Included in the Forbes list as one of the 100 best doctors in Spain , recognized for leadership and innovation in joint surgery using navigation technologies.
• Since 2008 : ISO 9001:2008 certification for quality of hip and knee replacement surgeries.

Membership in professional organizations

• International Member of the American Academy of Orthopaedic Surgeons .
• Member of the Spanish Association of Arthroscopy .

The doctor has established himself as a pioneer in the field of joint surgery, introducing innovative technologies such as navigation systems and minimally invasive approaches. His achievements and approach to patient recovery make him one of the leading specialists in Spain.

Education

2000
Medical School Graduate – Istanbul University, Faculty of Medicine

2005
Radiology Department, Istanbul University, Istanbul Medical Faculty

Work Experience

2022 – Present
Neolife Medical Center

2015 – 2021
Sonomed Imaging Center

2015
Bezmialem Vakıf University

2011 – 2015
Echomar Imaging Center

2010 – 2011
Istanbul Bilim University

2008 – 2009
Derince Military Hospital

2007 – 2008
German Hospital-Taksim

2005 – 2007
Echomar Imaging Center

Professional Trainings

• National Radiology Congresses
• National Magnetic Resonance Society Meetings

Memberships

• Turkish Radiology Society
• Turkish Magnetic Resonance Society
• Turkish Neuroradiology Society
• RSNA (Radiological Society of North America)
• ESR (European Society of Radiology)

Scientific Works

MRI findings in parosteal osteosarcoma: correlation with histopathology.
Dönmez FY, Tüzün U, Başaran C, Tunaci M, Bilgiç B, Acunaş G. Diagn Interv Radiol. 

The diagnostic efficiency of multislice CT virtual bronchoscopy in detecting endobronchial tumors.
Bakir B, Tüzün Ü, Terzibaşioğlu E, Dursun M, Güven K, Salmaslioğlu A, Tunaci A. Tuberk Toraks.

Diffusion MR findings in cyclosporin-A induced encephalopathy.
Aydin K, Donmez F, Tuzun U, Minareci O, Atamer T. Neuroradiology. 2004 

Diffusion tensor imaging findings of the brainstem in subjects with tonsillar ectopia.
Kurtcan S, Alkan A, Yetis H, Tuzun U, Aralasmak A, Toprak H, Ozdemir H. Acta Neurol Belg. 2018 Mar;

Diffusion Tensor Imaging Parameters in Children with Acute Hyperammonemic Encephalopathy Due to Urea Cycle Enzyme Defects and Organic Acidemia.
Kurtcan S, Alkan A, Guler S, Yesil G, Toprak H, Tuzun U, Yetis H, Aralasmak A, Ozdemir H, Iscan A. Current Medical Imaging Reviews. Volume 13, 2017 DOI: 10.2174/

The Contribution of DTI in Determining the Relationship of Epilepsy and Brain Lesions in Children with Tuberous Sclerosis.
Kurtcan S, Alkan A, Guler S, Yesil G, Toprak H, Tuzun U, Yetis H, Aralasmak A, Ozdemir H, Iscan A. Current Medical Imaging Reviews. Volume 13, 2017 DOI: 10.2174/

Brainstem cranial nerve diffusion changes in Wernicke encephalopathy secondary to necrotizing pancreatitis.
Kurtcan S, Alkan A, Aydin S, Tuzun U, Toprak H. Arch Med Sci Civil Dis 2016;1:e45–e50

Neuroimaging Features of Acquired Metabolic and Toxic Encephalopathies.
Ediz S.S, Kurtcan S, Alkan A, Aydin S, Tuzun U, Toprak H, Aralasmak A. Current Medical Imaging Reviews. Volume 13, 2017

Does the Application of Platelet-Rich Fibrin in Anterior Cruciate Ligament Reconstruction Enhance Graft Healing and Maturation? A Comparative MRI Study of 44 Cases.
Beyzadeoglu T, Pehlivanoglu T, Yildirim K, Buldu H, Tandogan R, Tuzun U. Orthop J Sports Med. 2020 Feb 20;8(2):

Deep learning for assessing image quality in bi-parametric prostate MRI: A feasibility study.
Alis D, Kartal MS, Seker ME, Guroz B, Basar Y, Arslan A, Sirolu S, Kurtcan S, Denizoglu N, Tuzun U, Yildirim D, Oksuz I, Karaarslan E. Eur J Radiol. 2023 Aug;165:110924. doi: 10.1016/j.ejrad.2023.110924. Epub 2023 Jun 11.

Awards

1. TMRD 16th Annual Meeting Film Reading Session - 2nd Prize (2011)
2. TMRD 17th Annual Meeting Film Reading Session - 3rd Prize (2012)
3. TMRD 17th Annual Meeting Case of the Day - 3rd Prize (2012)
4. TRD 33rd National Congress Case of the Day - 2nd Prize (2012)
5. TMRD 18th Annual Meeting Film Reading Session - 3rd Prize (2013)
6. TMRD 18th Annual Meeting Case of the Day - 3rd Prize (2013)
7. TMRD 19th Annual Meeting Film Reading Session - 2nd Prize (2014)
8. TMRD 19th Annual Meeting Case of the Day - 1st Prize (2014)
9. TRD 36th National Congress Case of the Day - 2nd Prize (2015)
10. TMRD 21st Annual Meeting Film Reading Session - 1st Prize (2016)
11. TRD 37th National Congress Case of the Day - 1st Prize (2016)
12. TMRD 37th National Congress Film Reading Session - 1st Prize (2016)
13. TMRD 23rd Annual Meeting Film Reading Session - 1st Prize (2018)

Education:

• 2008 – 2012: Marmara University School of Medicine (Specialization Training)
• 1998 – 2005: Istanbul University Cerrahpaşa School of Medicine

Work Experience:

• 2012 – Present: Neolife Medical Center

Memberships:

• Turkish Society of Radiation Oncology

Scientific Works:

2014:

• 11th National Radiation Oncology Congress
  • Oral Presentation: "Late-stage kidney damage after chemoradiotherapy in gastric cancer patients, clinical, functional, and dosimetric examination of tolerance doses."
  • Poster Presentation: "Early-stage stereotactic radiotherapy results in lung metastases."

2011:

• 1st Evidence-Based Medicine Course
  • "Evaluation of late side effects in patients treated with conformal radiotherapy for localized prostate cancer: A TOG Side Effects Subgroup Study."

Areas of Interest

• Breast Cancer
• Prostate Cancer
• Gastrointestinal System Tumors
• Gynecological Tumors
• Brain Tumors
• Lung Cancer

Education
2021:

• Professor Title, Health Sciences University Hamidiye Faculty of Medicine

2017 – 2018:

• Master's Degree in Phytotherapy, Department of Pharmacognosy, Faculty of Pharmacy, Istanbul University

2015:

• Associate Professor Title

1996:

• Radiation Oncology Specialization, Princess Margaret Hospital, Toronto, Canada

1994 – 1998:

• Radiation Oncology Specialization, Şişli Etfal Training and Research Hospital

1982 – 1988:

• Trakya University Faculty of Medicine

Work Experience
2024:

• Neolife Medical Center – Biruni University

2021 – 2024:

• Health Sciences University (Hamidiye Faculty of Medicine – Bursa Medical Faculty – Izmir Medical Faculty – Lecturer)

2020 – 2024:

• SBÜ Başakşehir Çam and Sakura City Hospital – Education and Administrative Officer

2015 – 2020:

• Dr. Sadi Konuk Training and Research Hospital – Radiation Oncology Clinical Department Setup and Administrative Officer

2013 – 2020:

• Gelişim University – Lecturer, Radiation Therapy Technician Program

2009 – 2015:

• Istanbul Training and Research Hospital, Radiation Oncology Center Setup, Clinical Administrative Responsibility, and Chief Assistant

1998 – 2009:

• Şişli Etfal Training and Research Hospital, Radiation Oncology Clinic Chief Assistant

Professional Trainings
2023:

• Project Creation and Development on Artificial Intelligence and Radiotherapy Treatment Planning Systems with Yıldız Technical University

2023:

• Hydrogel Space Oar Application and Certification Training, Başakşehir Çam and Sakura City Hospital

2015:

• Turkish Radiation Oncology Association (Mammography Working Group, Integrative Working Group, Stereotactic Working Group, Uro-Oncology Working Group), Researcher

2020:

• Hydrogel Space Oar Application and Certification Training, Başakşehir Çam and Sakura City Hospital

2018:

• Distance Good Clinical Practices Training; Basic Good Clinical Practices Course

2011:

• Lifelong Learning Program Leonardo da Vinci Mobility Projects, European Union Education and Youth Programs Directorate

2008:

• Brachytherapy Training, Istanbul University, Oncology Institute

Memberships
2022 – 2024:

• President of Sakura Science and Academician Association (SABADER)

2023:

• Turkish Radiation Oncology Association, Integrative Working Group Executive Board Member

2021:

• Cam & Sakura Medical Journal, Section Editor

2018:

• Interdisciplinary Oncology Association, Substitute Member of the Executive Board

1995:

• Turkish Radiation Oncology Association

1989:

• Turkish Medical Association

Scientific Works

• A.1 Karacetin D, Yalcin B, Okten B, Oztürk S, Maral O, Incekara O (2009). Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer. JBUON, 605-608
• A.2 Yılmaz O B, Karacetin D, Kabukcuoglu F, Taskin T, Yener S (2011). Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas. Pol J Pathol, 62(1), 19-24
• A.3 Karacetin D, Cakir A, Agaoglu F, Çamlıca H, Ergen A, Dizdar Y, Darendeliler E (2010). Dose distribution in 3-dimensional conformal radiotherapy for prostate cancer: comparison of femur doses for four treatment techniques. Journal of Radiotherapy in Practice, 41-51
• A.4 Baycan D, Karacetin D, Balkanay A, Barut Y (2012). Field-in-field IMRT versus 3D-CRT of the breast. Cardiac vessels, ipsilateral lung, and contralateral breast absorbed doses in patients with left-sided lumpectomy: a dosimetric comparison. Jpn J Radiol, DOI: 10.1007/s

Areas of Interest
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Skin Cancer
Stomach Cancer
Liver Cancer
Cervical Cancer
Kidney Cancer
Pancreatic Cancer
Esophageal Cancer

Education
2014 – 2017
Hacettepe University Oncology Institute, Department of Medical Oncology

2009 – 2013
Ufuk University Faculty of Medicine, Department of Internal Medicine

1999 – 2006
Eskişehir Osmangazi University Faculty of Medicine

Work Experience
2024
Neolife Medical Center

2024
Kolan Beylikdüzü Hospital

2023 – 2024
Memorial Bahçelievler Hospital

2020 – 2023
Acıbadem Maslak Hospital

2019 – 2020
İstanbul Aydın University VM Medicalpark Florya Hospital

2017 – 2019
Ministry of Health, Van Education and Research Hospital

2014 – 2017
Hacettepe University Oncology Institute, Medical Oncology Department

2013 – 2014
Kars State Hospital

2009 – 2013
Ufuk University, Dr. Rıdvan Ege Hospital, Department of Internal Medicine

2007 – 2009
Hacettepe University Faculty of Medicine, Department of Physiology

Professional Training
Participation in Turkish Medical Oncology Congresses, National Cancer Congresses, National Immunotherapy and Oncology Congresses
Courses of the Turkish Society of Medical Oncology

Memberships
Turkish Society of Medical Oncology
Istanbul Medical Chamber

Scientific Publications
6 scientific publications in national and international journals
21 abstracts presented at national congresses
3 abstracts presented at international congresses
1 book chapter translation: Atlas of Internal Medicine, 3rd Edition, Chapter 12 – Hepatology, Turkish Translation
3 book chapters:

1. Immunotherapy in Oncology. Immunotherapy in Small Cell Lung Cancer, Chapter 13, 2020
2. Endocrine System Tumors. The Role of Immunotherapy in Neuroendocrine Tumors, Chapter 41, 2021
3. Antineoplastic Drugs. Mechanisms of Action and Classification of Antimetabolites, Chapter 14, 2022
   1 oral presentation at a national congress: Chemotherapy in Cervical Cancer – 3rd National Urogenital Cancer Congress, 2019
   3 abstracts presented at international congresses

He completed two fellowships in spinal surgery, one in Aarhus, Denmark, with the support of the SICOT international society in 2012 and the second in complex spine surgery in Uppsala, Sweden, in 2016, with the support of a grant from the international society AOspine .

During his career, Dr. Covaro has a continuous participation in international meetings and contributed to several articles published in scientific magazines.

He has a great experience in the treatment of patients and uses the knowledge he has acquired to provide each patient with the best quality of care.

Dr. Covaro is a member of several professional organizations, including the Spanish Society of Orthopedics, AOspine, GEER and Eurospine.

During his career, Dr. Covaro has a continuous participation in international meetings and contributed to several articles published in scientific magazines. Dr. Covaro is a member of several professional organizations, including the Spanish Society of Orthopedics, AOspine, GEER and Eurospine.

Currently, Dr. Covaro attends his patients at the Institut Universitari Dexeus and the Hospital Universitari de Bellvitge, in Barcelona. To make an appointment with Dr. Augusto Covaro, contact ICATME, Institut Universitari Dexeus

KTU Faculty of Medicine 2005-2011

Izmir Ege University Faculty of Medicine Hospital Department of Brain and Nerve Surgery

2011-2017 Erzincan BY University Faculty of Medicine

2017-2023 Izmir University of Economics Medicalpark Hospital

 

AREAS OF INTEREST AND TREATMENT METHODS USED;

Spine Surgery

Lumbar hernias, (fully closed herniated disc surgery, microsurgery herniated disc surgery)

Cervical hernias (fully closed cervical disc herniation surgery, microsurgery cervical disc herniation surgery)

Spinal Fracture Treatment (open surgery and fully closed surgery = kyphoplasty vertebroplasty)

Scoliosis (Spine Curvatures)

Ankylosing Spondylitis (Hunchback)

Spine Tumors

Nerve Compression

Endoscopic (Closed Method) Brain Tumor Surgeries

Brain tumor surgery with neuronavigation

Brain Hemorrhages

Pain Intervention Procedures (Radiofrequency, Laser)

Hydrocephalus (accumulation of water in the brain)

Congenital Anomalies

Minimally Invasive Procedures and Head Traumas.

Education

• 1992-1999 Hacettape University
• 2000-2004 Dokuz Eylül University
• 2007 Al-Azhar University
• 2009 Al-Shefa Medical Complex

Memberships

• 2016 TOAK Turkish Orthopedic Research Council
• 2015 TOTBİD
• 2005 Egyptian Orthopaedic Association EOA

Experience

• 2004-2009 Balsam Hospitals, Gaza / Palestine
• 2009-2013 AL-SHIFA Training and Research State Hospital, Gaza / Palestine
• 2007-2013 Al-Azhar University Faculty of Medicine, Gaza / Palestine
• 2014-2015 Private Karatas Hospital, Izmir / Turkey
• 2015-2016 Private Gazi Kent Surgical Medical Center, Izmir / Turkey
• 2015-2016 West Anatolia Central Hospital, Izmir / Turkey
• 2016 Catalca State Hospital, Istanbul / Turkey

Gastroenterologist

Crohn's disease

Ulcerative colitis

Other autoimmune diseases

Gastritis

Ulcers of the stomach and duodenum

Precancerous conditions of the gastrointestinal tract

Irritable bowel syndrome

Chronic diarrhea

Chronic constipation, etc.

SPECIALIZATION:

Gastroenterologist

EDUCATION:

Azerbaijan State Medical University

COURSES:

Graduated from the Azerbaijan State Medical University. In different years, he participated in seminars held in Azerbaijan by German, Colombian, Swiss, Russian and Ukrainian specialists on "Basics of Homotoxicology", gastroenterology, isopathy, acupuncture and neurotherapy, and received the relevant certificates. At the Sisli Etfal Hospital Egitim Araştırma in Istanbul he attended the refresher courses on "Metabolic Disorders and Obesity", Ege University of Izmir on "Inflammatory Bowel Diseases" and at the same time he attended the Congress on Bioregulatory Drugs in Germany. He attended the courses held Individual Medical Association in Ankara, on the topic of "-CGF and Serum Ozonation". Currently working as a gastroenterologist in the clinic of biological medicine. Has successful results in the treatment of a number of chronic diseases of the gastrointestinal tract.

EXPERIENCE:

21 years old

Viral hepatitis A, B, C, D

Cirrhosis

Autoimmune liver diseases

Fatty liver

Diseases of the stomach and intestines

Diseases of the pancreas

Services in the field of biological medicine:

Treatment of various drug-induced liver poisonings, viral hepatitis (hepatitis B, hepatitis C), hepatosis, hepatosterosis, autoimmune hepatitis.

EDUCATION: Azerbaijan Medical University

EXPERIENCE:

2009-2010 General practitioner in a private clinic.

Clinic of biological medicine since 2011.

TRAINING AND MEMBERSHIP:

In 2013-2014, internship on viral hepatitis at the Department of Microbiology and Infection, as well as at the Department of Gastroenterology, Faculty of Medicine, Ege University, Turkey.

Ankara Hacettepe Hospital

Head of the Center for Maternity and Reproductive Technologies, Obstetrician-Gynecologist